Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Evexia LifecareBOM:524444 -3.05%64 EBITDA Margin % is 3.28% as of Mar. 2026, which is 30% above its 10-year median of 2.52. GuruFocus rates BOM:524444 with a GF Score™ of 64/100 and a GF Value™ of ₹1.59 (Fairly Valued). The stock has 5 warning signs investors should review. Among 1,958 Consumer Packaged Goods companies, Evexia Lifecare ranks worse than 75.18% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Evexia Lifecare's EBITDA for the
three
months ended in Mar. 2026 was ₹12 Mil. Evexia Lifecare's Revenue for the
three
months ended in Mar. 2026 was ₹368 Mil. Therefore, Evexia Lifecare's EBITDA margin for the quarter that ended in Mar. 2026 was 3.28%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Evexia Lifecare EBITDA Margin % Related Terms
Evexia Lifecare EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Evexia Lifecare's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524444 vs KHC, GIS: EBITDA Margin % Comparison
For the Packaged Foods subindustry, Evexia Lifecare's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evexia Lifecare EBITDA Margin % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Evexia Lifecare's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Evexia Lifecare's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evexia Lifecare (BOM:524444) has a EBITDA Margin % of 3.28% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Evexia Lifecare and its competitors. This is 30% above median its historical median of 2.52. Over the past decade, Evexia Lifecare's EBITDA Margin % has ranged from 0.80 to 5.39. According to the industry distribution chart, Evexia Lifecare ranks #1472 out of 1958 companies in the Consumer Packaged Goods industry, placing it in the top 75.2%.
Is Evexia Lifecare's EBITDA Margin % too high?
Evexia Lifecare's current EBITDA Margin % of 3.28% is 30% above median its 10-year median of 2.52. Over the past 10 years, this metric has ranged from a low of 0.80 to a high of 5.39. The Consumer Packaged Goods industry median EBITDA Margin % is 8.98. Evexia Lifecare's value of 3.28% is 63.5% below this industry median. Based on the distribution chart, Evexia Lifecare ranks #1472 out of 1958 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers. Overall, Evexia Lifecare has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evexia Lifecare's EBITDA Margin % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Evexia Lifecare ranks #1472 out of 1958 companies for EBITDA Margin %. This places Evexia Lifecare in the lower half of its industry. The industry median EBITDA Margin % is 8.98. Evexia Lifecare's value of 3.28% is 63.5% below this benchmark. Historically, Evexia Lifecare's own EBITDA Margin % has ranged from 0.80 to 5.39 over the past decade. While the company's 10-year median is 2.52 vs. the industry median of 8.98, Evexia Lifecare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Consumer Packaged Goods company?
The median EBITDA Margin % among Consumer Packaged Goods companies is 8.98, based on 1,958 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Evexia Lifecare's current EBITDA Margin % of 3.28% is 63.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Evexia Lifecare and its competitors. For the Consumer Packaged Goods industry, the median EBITDA Margin % is 8.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Evexia Lifecare's current EBITDA Margin % is 3.28%, which is 30% above median its own 10-year median of 2.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evexia Lifecare stock overvalued right now?
Based on GuruFocus' analysis, Evexia Lifecare (BOM:524444) is currently considered Fairly Valued. The stock's GF Value™ is ₹1.59, compared to a current price of ₹1.59 — trading right at its estimated fair value. The current EBITDA Margin % is 3.28%, which is 30% above median its 10-year median of 2.52 and 63.5% below the Consumer Packaged Goods industry median of 8.98. Evexia Lifecare's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Evexia Lifecare (BOM:524444), the current EBITDA Margin % is 3.28% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evexia Lifecare (BOM:524444) Overvalued in 2026?
Based on GuruFocus' analysis, Evexia Lifecare stock appears to be undervalued.
The current stock price of ₹1.59 is trading 0% below its estimated GF Value™ of ₹1.59.
GuruFocus considers Evexia Lifecare to be Fairly Valued.
Key valuation signals for BOM:524444:
EBITDA Margin %: 3.28% (30% above median its 10-year median of 2.52)
GF Value™: ₹1.59 vs. price of ₹1.59 (0% below fair value)
Industry Position: 63.5% below the Consumer Packaged Goods median (#1472 of 1958)
No single metric tells the full story. See the BOM:524444 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evexia Lifecare Ltd diversified healthcare company specializing in the trading of pharmaceutical chemicals, retail pharmacy services, diagnostic solutions, and personal healthcare products, committed to improving well-being with quality and reliability.
64GF Score
Get the complete analysis for BOM:524444
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524444 has been successfully added to your 
